• 0 Citations
  • 0 h-Index
20102018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Holly Pacenta is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Multipotent Stem Cells Medicine & Life Sciences
CXCR4 Receptors Medicine & Life Sciences
Femoral Nerve Medicine & Life Sciences
Bone Neoplasms Medicine & Life Sciences
Neural Stem Cells Medicine & Life Sciences
Nerve Block Medicine & Life Sciences
Chemokine Receptors Medicine & Life Sciences
Fibroblast Growth Factor 2 Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2010 2018

Entrectinib and other ALK/TRK inhibitors for the treatment of neuroblastoma

Pacenta, H. L. & Macy, M. E., Jan 1 2018, In : Drug Design, Development and Therapy. 12, p. 3549-3561 13 p.

Research output: Contribution to journalReview article

Open Access
Neuroblastoma
Neoplasms
Therapeutics
Clinical Trials, Phase I
Proteins

Chemokine receptor CXCR4 signaling modulates the growth factor-induced cell cycle of self-renewing and multipotent neural progenitor cells

Li, M., Chang, C. J., Lathia, J. D., Wang, L., Pacenta, H. L., Cotleur, A. & Ransohoff, R. M., Jan 1 2011, In : GLIA. 59, 1, p. 108-118 11 p.

Research output: Contribution to journalArticle

Multipotent Stem Cells
CXCR4 Receptors
Neural Stem Cells
Chemokine Receptors
Fibroblast Growth Factor 2

Continuous tunnelled femoral nerve block for palliative care of a patient with metastatic osteosarcoma

Pacenta, H. L., Kaddoum, R. N., Pereiras, L. A., Chidiac, E. J. & Burgoyne, L. L., May 1 2010, In : Anaesthesia and Intensive Care. 38, 3, p. 563-565 3 p.

Research output: Contribution to journalArticle

Femoral Nerve
Bone Neoplasms
Nerve Block
Osteosarcoma
Palliative Care